APS
2025 APS Annual Convention · 2025
Intranasal Oxytocin to Treat Mental Disorders: A Meta-Analysis of Randomized Controlled Trials
- Justin Bonnieux
Concordia University, Montreal, QC. - Kellie-Anne Bélisle
Concordia University - Alexandra Harboun
Concordia University - Alexandra Haddad
Concordia University - Alison McLellan
Concordia University - Leo Chester-Trudel
Concordia University - Olivia Quintus-Bosz
Concordia University - David Garred
Concordia University - Florencia Trespalacios
Concordia University - Tiffany Resendes
Concordia University - Stephanie Gumuchian
Concordia University - Mark Ellenbogen
Concordia University
Abstract
Intranasal oxytocin has received growing attention for its potential to improve the treatment of mental disorders. The current systematic review is the first to meta-analyze clinical outcomes across psychiatric diagnoses since 2013. Overall efficacy was null; meta-regressions will uncover key individual and contextual factors influencing oxytocin’s effects in clinical populations.
Psychopathology